Latest available resultsQuarter ended June 30, 202610-Q · July 21, 2026
Filed with the SECINTUITIVE SURGICAL INC
ISRGHealthcare
Next reportOctober 19, 2026after close · Analyst forecast 2.689 $/share
Revenue
$2.89B
▲ +18.5% vs prior year% YoY
Net income
$818.10M
▲ +24.3% vs prior year% YoY
EPS
2.29$
▲ +26.5% vs prior year% YoY
Net margin
28.3%
▲ +1.3 percentage points vs prior year pp YoY
Revenue▲ +18.5 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +24.3 %
EPS▲ +26.5 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $2.89B | |
| Gross profit | $1.96B | 67.8 % |
| Operating income | $971.90M | 33.6 % |
| Net income | $818.10M | 28.3 % |
| R&D | $370.60M | 12.8 % |
| EPS (diluted) | 2.29 $ | |
| Balance sheet | ||
| Assets | $20.88B | |
| Liabilities | $2.58B | |
| Equity | $18.30B | |
| Cash | $2.76B | |
| Capital | ||
| Shares outstanding | 353.28M | as of 2026-07-16 |
| Public float | — | |